Articles by Bart Schaneman :
Etain gets OK to produce expanded medical marijuana line in New York
New York medical marijuana company Etain is the first to receive state approval to expand its product line.
Delay in Washington state’s marijuana seed-to-sale system causes diversion concerns
Washington state marijuana businesses won’t have a government-run seed-to-sale tracking program for at least another month, causing industry insiders to worry that the prolonged delay could lead to diversion and other compliance issues.
The state’s Liquor and Cannabis Board was planning to implement Denver-based MJ Freeway’s Leaf Data Systems on Jan. 1 but instead has delayed the target rollout date to Feb. 1.
Marijuana ETF begins trading on US exchange
Marijuana investors have a new fund to watch as the new year approaches.
ETFMG Alternative Harvest ETF – a cannabis-focused exchange-traded fund – made its debut on NYSE Arca this week with 31 holdings.
